MS Therapy Archive - MS-Docblog

Animation der Blutbahn und Immunzellen mit Wirkstoff

The Epstein-Barr Virus (EBV) – Facts and Considerations on Infection (2)

11. September 2024 Prof. Dr. med. Mathias Mäurer General

The Epstein-Barr virus (EBV) belongs to the family of herpes viruses. EBV was first identified as a human tumor virus in Burkitt’s lymphoma (an aggressive blood cancer of the B-cell series) and has subsequently been

The Epstein-Barr Virus (EBV) – Facts and Considerations (1)

11. September 2024 Prof. Dr. med. Mathias Mäurer General

The Epstein-Barr virus, or EBV for short, often causes confusion in connection with multiple sclerosis. Therefore, this is the start of the first of three parts with facts and considerations about EBV and MS. In

Update Radiologically Isolated Syndrome (RIS)

16. May 2024 Prof. Dr. med. Mathias Mäurer Diagnosis MS, Therapy for MS

Radiologically isolated syndrome (RIS) refers to an incidental finding in magnetic resonance imaging (MRI) where lesions typical of multiple sclerosis (MS) are found, even though the MRI was not performed under clinical suspicion of MS,

Bei Multipler Sklerose helfen Medikamente. Die können aber auch Nebenwirkungen haben.

Side Effect of MS Medications: Ocrelizumab

26. May 2023 Prof. Dr. med. Mathias Mäurer Therapy for MS

Ocrelizumab (Ocrevus®) is a monoclonal antibody and belongs to the group of so-called B-cell-depleting therapies, which currently play a very important role in the immunotherapy of Multiple Sclerosis. They are used quite frequently. This article

High-Dose Biotin is a Dead End

2. July 2021 Prof. Dr. med. Mathias Mäurer Therapy for MS

The treatment options for progressive MS are limited – so interest was high when the study data on the use of high-dose biotin in progressive MS was first presented at the American Neurology Congress in

Immunity Against Viral Infections – Adaptive Immunity

19. March 2020 Prof. Dr. med. Mathias Mäurer General

The immune defense against microorganisms is carried out with the help of two lines of defense – the first line of defense, the so-called innate immunity (innate immunity) reacts quickly but unspecifically and is mediated

Approval of Siponimod in the USA and Europe – the vote of the regulatory authorities

18. November 2019 Prof. Dr. med. Mathias Mäurer MS Therapy

The new MS drug Siponimod, the further development of Fingolimod (Gilenya®), was recently approved by the Food and Drug Administration (FDA) in the USA and has been available there for some time for MS patients

Tag: MS Therapy

The Epstein-Barr Virus (EBV) – Facts and Considerations on Infection (2)

The Epstein-Barr Virus (EBV) – Facts and Considerations (1)

Update Radiologically Isolated Syndrome (RIS)

Side Effect of MS Medications: Ocrelizumab

High-Dose Biotin is a Dead End

Immunity Against Viral Infections – Adaptive Immunity

Approval of Siponimod in the USA and Europe – the vote of the regulatory authorities

Thank You!

Recent Posts

Archive

Categories

Links

Follow us

The Expert

The Topics

The Community